Navigation Links
Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
Date:5/22/2008

CAM)-expressing solid tumors. Micromet is developing adecatumumab in collaboration with Merck Serono in a phase 1b clinical trial evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. The fourth clinical stage antibody is MT293 which is licensed to TRACON Pharmaceuticals, Inc. and is being developed in a phase 1 clinical trial for the treatment of patients with cancer. In addition, Micromet has established a collaboration with Nycomed for the development and commercialization of MT203, a human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid arthritis, psoriasis, or multiple sclerosis.

Forward-Looking Statements

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product candidates that appeared promising in early research, preclinical studies or clinical trials do not demonstrate safety and/or efficacy in subsequent clinical trials, the risk that encouraging results from early research, preclinical studies or clinical trials may not be confirmed upon further analysis of the detailed results of such research, preclinical study or clinical trial, the risk that additional information relating to the safety, efficacy or tolerability of our product candidates may be discovered upon further analysis of preclinical or clinical trial data, the risk that we or our collaborators will not obtain approval to market our product candidates, the risks associated with reliance on ou
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
2. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
3. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
4. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
5. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
6. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
7. Micromet Announces Changes in Management Team
8. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
9. Abbott Presents Long-Term Data From Extension Study Showing Adult Crohns Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
10. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
11. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... MOUNTAIN VIEW, Calif. , July 23, 2014 ... translational preclinical research, today unveiled their new logo and ... transformation of Surpass, corporate culture to one where our ... This press release comes on the heels of the ... to the Silicon Valley Team:  David Craig, a veteran ...
(Date:7/23/2014)... , July 23, 2014 Pharmavite LLC ... company,s chief customer officer effective immediately. Toll recently served ... sales and marketing, category management, private label and sales ... In his new global role, Toll will expand his ... sales planning. "Toll,s appointment to chief customer ...
(Date:7/23/2014)... DALLAS , July 23, 2014 ... LLC ("Plaintiff") filed suit in the 116 ... Dallas, Texas , against RegenLab USA, ... Current and Prospective Business Relationships through false ... interference; and, Business Disparagement through libel, ...
Breaking Medicine Technology:SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 2SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 3
... CARLSBAD, Calif., Nov. 24 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... present a company overview at Piper Jaffray,s 21st Annual Health Care ... The New York Palace Hotel. , A live audio webcast of ... of the Company,s Web site, www.isispharm.com . A replay ...
... , SAN MATEO, Calif., Nov. 24 NeurogesX, Inc. (Nasdaq: ... commercializing novel pain management therapies, today announced the appointment of ... 19, 2009. Mr. Orwin is a 20-year sales and marketing ... the launch of several important therapeutics. , Mr. Orwin currently ...
Cached Medicine Technology:NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 2NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 3NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 4
(Date:7/23/2014)... WEDNESDAY, July 23, 2014 (HealthDay News) -- Regularly checking ... another stroke, researchers report. "Screening pulse is the ... people over age 65 who have never had a ... effective, noninvasive and easy way to identify people who ... stroke," said study author Dr. Bernd Kallmunzer, of Erlangen ...
(Date:7/23/2014)... Agricultural and Forestry University in Shaanxi province, and the ... agreement that lays the groundwork for establishing the Sino-U.S. ... The signing ceremony was held in the city of ... the U.S. Department of Agriculture and China,s Ministry of ... event for UC Davis and for our World Food ...
(Date:7/23/2014)... Coral, FL (PRWEB) July 23, 2014 Rich ... announce the success of their charity yard sale to support ... was raised and 100% of the proceeds will be donated ... at the event are being donated to the Habitat for ... Fort Myers, Florida 33903. , One of the highlights ...
(Date:7/23/2014)... Global Cardio Care, Inc., a management ... (EECP), is celebrating the 100th birthday of Albert ... health center. , Weber has been plagued with ... EECP therapy since 1999, he no longer suffers from ... Global Cardio Care, introduced the Sara Soulati Health ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Bodybuilding.com, the ... online retailer of nutritional supplements, has officially opened the ... BPI SPORTS , the fastest growing sports nutrition company, ... , Brand of the Year, Best Tasting Protein of ... Protein Powder of the year - Whey-HD™, Pre-workout Supplement ...
Breaking Medicine News(10 mins):Health News:Routine Pulse Check May Prevent Second Stroke, Study Says 2Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:Rich Dad Education Charity Yard Sale Raises Over $650 for Habitat for Humanity of Lee and Hendry Counties 2Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3
... 9 After an extensive national search, Robert Croner has been ... of Philadelphia. , , Croner has spent ... the executive level for the past 20 years. Prior to ... Human Resources. , , "The knowledge that ...
... FLEMINGTON, N.J., Sept. 9 HCD Research announced today ... Obama,s speech on health care reform tonight to obtain Americans, ... reform. , , (Logo: ... Research will conduct the study using its MediaCurves.com(R) website among ...
... , , MONTREAL, Sept. 9 ... to announce the introduction of the new "Low Power, Low ... space, budget and energy sensitive healthcare enterprises and medical imaging professionals. , ... serving RAD Series , the RAD LPX line offers ...
... A news conference and tour of Pittsburgh,s newest state-of-the-art continuing ... p.m., Thursday, September 10. , , The $225 ... John Kane Hospital just off Bower Hill Road in Scott Township. ... executive officer Todd Swortzel will be available for questions with a ...
... Sept. 9 Just since midnight, over 50,000 letters have ... a new campaign to bring attention to the rising numbers ... as National "How Much Longer" Day for Autism ... agencies, Department of Education, lawmakers and the Obama Administration asking ...
... WASHINGTON, Sept. 9 The United We Serve program helped involve ... notable increase in young volunteers, in particular, since the launch of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ) , , The ... Friday, September 11, with a National Day of Service and Remembrance. ...
Cached Medicine News:Health News:The Children's Hospital of Philadelphia Names New Senior Vice President of Human Resources 2Health News:Research Firm will Obtain Americans' Reactions to the President's Speech on Health Care Reform 2Health News:Matrox Announces the New RAD LPX Series for Medical Imaging 2Health News:Matrox Announces the New RAD LPX Series for Medical Imaging 3Health News:With All Eyes On Swine Flu, Thousands of Parents Ask President Obama 'How Much Longer' Until Autism Gets Similar Attention 2Health News:With All Eyes On Swine Flu, Thousands of Parents Ask President Obama 'How Much Longer' Until Autism Gets Similar Attention 3Health News:Red Cross Sees Increase in Youth Volunteers During United We Serve Program 2Health News:Red Cross Sees Increase in Youth Volunteers During United We Serve Program 3
... Pump™ is a quiet, compact, efficient vacuum ... The oil-free design and TEFLON®/ETFE coated vapor ... reliability and reduced maintenance. Unique features include ... protection, and a 1-liter post-pump solvent recovery ...
Produces vacuum pressures required for 96 well kits...
... DirectPrep 96 plates and MinElute 96 ... sample handling and accelerated processing; ... plates and MinElute 96 UF PCR ... of internal components by simply separating ...
For vacuum-driven processing of spin columns; Reduced sample handling and accelerated processing; Parallel sample processing using QIAGEN spin columns; Easy cleaning of internal components by simpl...
Medicine Products: